Cargando…
Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease
BACKGROUND: To better understand the patient's heterogeneity in fatty liver disease (FLD), metabolic dysfunction–associated fatty liver disease (MAFLD) was proposed by international experts as a new nomenclature for nonalcoholic fatty liver disease (NAFLD). We aimed to evaluate the cardiovascul...
Autores principales: | Perdomo, Carolina M., Núñez-Córdoba, Jorge M., Ezponda, Ana, Mendoza, Francisco J., Ampuero, Javier, Bastarrika, Gorka, Frühbeck, Gema, Escalada, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632176/ https://www.ncbi.nlm.nih.gov/pubmed/36341262 http://dx.doi.org/10.3389/fmed.2022.1023583 |
Ejemplares similares
-
Transient elastography and serum markers of liver fibrosis associate with epicardial adipose tissue and coronary artery calcium in NAFLD
por: Perdomo, Carolina M., et al.
Publicado: (2022) -
Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease
por: Perdomo, Carolina M., et al.
Publicado: (2019) -
Evaluation of Dietary and Alcohol Drinking Patterns in Patients with Excess Body Weight in a Spanish Cohort: Impact on Cardiometabolic Risk Factors
por: Aguas-Ayesa, Maite, et al.
Publicado: (2023) -
Diabetic Kidney Disease, Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease: A New Triumvirate?
por: Perdomo, Carolina M., et al.
Publicado: (2021) -
BMI-based obesity classification misses children and adolescents with raised cardiometabolic risk due to increased adiposity
por: Zapata, J. Karina, et al.
Publicado: (2023)